Globe Life Inc. GL
We take great care to ensure that the data presented and summarized in this overview for GLOBE LIFE INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding GL
View all-
Vanguard Group Inc Valley Forge, PA10MShares$1.32 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY6.1MShares$804 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.85MShares$507 Million0.09% of portfolio
-
State Street Corp Boston, MA3.24MShares$427 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA2.81MShares$370 Million0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA2.72MShares$359 Million0.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.08MShares$274 Million0.07% of portfolio
-
Morgan Stanley New York, NY1.73MShares$229 Million0.02% of portfolio
-
Aqr Capital Management LLC Greenwich, CT1.39MShares$183 Million0.13% of portfolio
-
Nuveen, LLC Charlotte, NC1.14MShares$150 Million0.04% of portfolio
Latest Institutional Activity in GL
Top Purchases
Top Sells
About GL
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole life, term life, and other life insurance products; Medicare supplement and supplemental health insurance, such as critical illness and accident plans; and single-premium and flexible-premium deferred annuities. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was incorporated in 1979 and is headquartered in McKinney, Texas.
Insider Transactions at GL
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 02
2026
|
Marilyn A Alexander Director |
BUY
Grant, award, or other acquisition
|
Direct |
458
+1.99%
|
-
|
|
Jan 02
2026
|
Alice S Cho Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,373
+18.94%
|
-
|
|
Jan 02
2026
|
Mary E Thigpen Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,373
+6.82%
|
-
|
|
Jan 02
2026
|
Cheryl Alston Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,373
+11.25%
|
-
|
|
Jan 02
2026
|
Linda Addison Director |
BUY
Grant, award, or other acquisition
|
Direct |
723
+3.42%
|
-
|
|
Jan 02
2026
|
James Brannen Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,373
+11.97%
|
-
|
|
Jan 02
2026
|
Philip M Jacobs Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,373
+34.88%
|
-
|
|
Jan 02
2026
|
David A Rodriguez Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,373
+15.97%
|
-
|
|
Jan 02
2026
|
Matthew J Adams Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,373
+34.95%
|
-
|
|
Jan 02
2026
|
Mark A Blinn Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,373
+17.45%
|
-
|
|
Dec 19
2025
|
Frank M Svoboda Co-Chairman & CEO |
BUY
Bona fide gift
|
Indirect |
26,425
+50.0%
|
-
|
|
Dec 19
2025
|
Frank M Svoboda Co-Chairman & CEO |
SELL
Bona fide gift
|
Indirect |
26,425
-19.59%
|
-
|
|
Dec 16
2025
|
Frank M Svoboda Co-Chairman & CEO |
SELL
Open market or private sale
|
Direct |
9,379
-10.89%
|
$1,313,060
$140.53 P/Share
|
|
Dec 16
2025
|
Frank M Svoboda Co-Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+21.65%
|
$1,025,000
$82.56 P/Share
|
|
Dec 12
2025
|
Michael Shane Henrie SVP & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,065
-50.2%
|
$426,035
$139.1 P/Share
|
|
Dec 12
2025
|
Michael Shane Henrie SVP & Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,065
+33.42%
|
$367,800
$120.49 P/Share
|
|
Nov 13
2025
|
Robert Brian Mitchell EVP, General Counsel and CRO |
BUY
Bona fide gift
|
Indirect |
283
+13.25%
|
-
|
|
Nov 13
2025
|
Robert Brian Mitchell EVP, General Counsel and CRO |
SELL
Bona fide gift
|
Indirect |
2,091
-5.08%
|
-
|
|
Oct 24
2025
|
Robert Brian Mitchell EVP, General Counsel and CRO |
SELL
Open market or private sale
|
Direct |
91,000
-63.43%
|
$12,194,000
$134.24 P/Share
|
|
Oct 24
2025
|
Robert Brian Mitchell EVP, General Counsel and CRO |
BUY
Exercise of conversion of derivative security
|
Direct |
91,000
+29.83%
|
$9,100,000
$100.76 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 91.8K shares |
|---|---|
| Exercise of conversion of derivative security | 365K shares |
| Bona fide gift | 26.7K shares |
| Open market or private sale | 353K shares |
|---|---|
| Payment of exercise price or tax liability | 23.9K shares |
| Bona fide gift | 38.5K shares |